Results 141 to 150 of about 147,528 (279)

Dupilumab for the Treatment of Cutaneous Immune‐Related Adverse Events: A Systematic Review

International Journal of Dermatology, EarlyView.
ABSTRACT The emergence of immune checkpoint inhibitors has revolutionized the landscape of cancer treatment in the modern era. However, cutaneous immune‐related adverse events (cirAEs) are common, significantly affecting patients' quality of life and often leading to treatment discontinuation, which may compromise oncological outcomes.
Ioannis‐Alexios Koumprentziotis, Aikaterini Niforou, Antonios Tsimpidakis, Christos Nikolaou, Alexander Stratigos, Vasiliki Nikolaou   +5 more
wiley   +1 more source

Cutaneous T‐cell lymphoma: 2017 update on diagnosis, risk‐stratification, and management

American journal of hematology/oncology, 2017
R. Wilcox
semanticscholar   +1 more source

Comprehensive study of anaplastic large cell lymphoma: clinicopathological features from Indonesia. [PDF]

BMC Res Notes
Harahap AS, Santoso I, Charles S, Mulansari NA, Ham MF.   +4 more
europepmc   +1 more source

Incidence trends of primary cutaneous B‐ and T‐cell lymphoma before and after the COVID‐19 pandemic

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Ioannis‐Alexios Koumprentziotis, Aikaterini Niforou, Stella Kaliampou, Antonios Tsimpidakis, Maria Gerochristou, Leonidas Marinos, Alexander Stratigos, Evangelia Papadavid, Vasiliki Nikolaou   +8 more
wiley   +1 more source

Current Evidences and Future Perspectives in the Management of Metastatic Non‐Clear Cell Renal Cell Carcinoma

International Journal of Urology, EarlyView.
ABSTRACT Renal cell carcinoma is a heterogeneous disease with diverse phenotypes. Renal cell carcinoma classification is based on morphological and molecular characteristics and falls into 2 main categories: clear cell renal cell carcinoma and non‐clear cell renal cell carcinoma.
Shotaro Nakanishi, Junichi Inokuchi
wiley   +1 more source

Scalp Involvement in Primary Cutaneous Lymphomas-An Update on Clinical Presentation, Diagnostics, and Management. [PDF]

Cancers (Basel)
Kołkowski K, Sławińska M, Zagórska B, Nowicki RJ, Jankau J, Sokołowska-Wojdyło M.   +5 more
europepmc   +1 more source

Sketching T cell atlases in the single‐cell era: challenges and recommendations

Immunology &Cell Biology, EarlyView.
Recent advances in single‐cell technologies have enabled the creation of T cell atlases, providing detailed maps of adaptive immunity across tissues, development and disease states. These atlases help uncover T cell diversity, functional states and disease mechanisms, aiding in the identification of therapeutic targets.
Itana Bojović, António GG Sousa, Sini Junttila, Laura L Elo   +3 more
wiley   +1 more source

Clinical characteristics, treatment patterns, and survival outcomes of 1031 patients with peripheral T cell lymphoma in china: a multicenter, real-world study. [PDF]

Discov Oncol
Huang L, Yang Y, Zhao Z, Zhou S, Wu J, Wang N, Zhang F, Shi K, Li C, Wei X, Zhang H, Lin Y, Li G, Zhou H, Guo H, Jiang X, Wei X, Chen F, Liu S, Lin C, Liang Z, Huang Y, Pan L, Yang H, Jiang Y, Wu Y, Cheng S, Yang H, Zheng X, Chen X, Li X, Huang G, Zhou J, Peng Z, Lin LE, Liu T, Li W.   +36 more
europepmc   +1 more source

Comprehensive analysis of cutaneous T‐cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy

Cancer, 2017
F. Ghazawi, E. Netchiporouk, E. Rahme, M. Tsang, L. Moreau, S. Glassman, N. Provost, M. Gilbert, Sara-Élizabeth Jean, K. Pehr, D. Sasseville, I. Litvinov   +11 more
semanticscholar   +1 more source

Primary cutaneous CD8‐positive aggressive epidermotropic cytotoxic T‐cell lymphoma initially demonstrating near‐complete metabolic response to BV‐CHEP

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Tristen Tze Wei Ng, Aaron James Frederiks, Jean‐Frank Iacobelli, Hun Sheng Chuah, Dejan Radeski, Thomas Anthony Delaney   +5 more
wiley   +1 more source